12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Stellar Imaging System

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

ELMED

FDA UDI
ELMED INCORPORATED·00842180159051·MALLEBALE TAPERED BLACK BLADE 1/4" X 3/4" WIDE,...

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776191016·Tapered Retractor Blade

VDRIVE SYSTEM/ VDRIVE DUO/ VDRIVE WITH V-CAS

FDA 510(k)
FDA Class 2 ·Cardiovascular

EXCALIBUR LIGHT THERAPY SYSTEM, MODEL SGIEX-04-001

FDA 510(k)
FDA Class 2 ·Physical Medicine

ANN PH NAIL RT 10X220MM

FDA Adverse Event
Injury ·ZIMMER GMBH·Product code HSB·January 26, 2026

ANN BLUNT TIP SCREW 4X40MM

FDA Adverse Event
Injury ·ZIMMER GMBH·Product code HSB·January 26, 2026

STYLE 10 SILICONE GEL FILLED BREAST IMPLANT

FDA Adverse Event
Injury ·ALLERGAN (COSTA RICA)·Product code FTR·August 1, 2025

GORE PROPATEN VASCULAR GRAFT

FDA Adverse Event
Injury ·W.L. GORE & ASSOCIATES·Product code DSY·November 21, 2008

LIFEVEST WCD 4000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·August 10, 2011

GYNECARE MORCELLEX TISSUE MORCELLATOR

FDA Adverse Event
Malfunction ·ETHICON INC.·Product code HET·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014